QTS

A Cretex Medical company

  • Our Approach
  • Services
    • Pre-Validated Medical Packaging
    • Package Design Expertise
    • Materials Sourcing
    • Engineering Validations
    • Label Development & Printing
    • Critical Inspection Services
    • Cleaning & Passivation
    • Cleanroom Assembly, Kitting & Packaging
    • Sterilization Services
    • Lab Testing Services
    • Supply Chain Management
  • Quality
    • Procedural Guidelines
  • Resources
  • News & Events
  • About
    • Vision and Values
    • Leadership
    • Power of Cretex Medical
  • Contact
  • Careers
  • News
  • Events
  • Blog

First FDA 510(k) Clearance for a Medical Device Sterilized Using Nitrogen Dioxide

June 3, 2016 by QTS Medical Device Outsourcing

Sopheak Srun Photo

Authored by Sopheak Srun, MPH, SM(NRCM), QTS Principal Sterilization Specialist

Noxilizer, one of QTS’ partners in the medical device industry, has recently announced the first FDA 510(k) clearance of a medical device sterilized by a nitrogen dioxide (NO2) process. Nitrogen dioxide sterilization is relatively new to the medical device industry and provides an alternative sterilization method that can be used for a growing number of drugs, biologics, and medical devices that might be incompatible with ethylene oxide, gamma radiation, and other conventional sterilization methods.

FDA 510(k) clearance of a medical device sterilized by nitrogen dioxide signifies a major milestone for nitrogen dioxide sterilization processes. In the FDA’s latest guidance for 510(k) submissions, the FDA categorizes sterilization processes as either “established” (which includes conventional sterilization methods such as ethylene oxide, gamma radiation, electron beam, steam, and dry heat), or “novel” (which includes technologies without an established history for sterilizing medical devices, such as nitrogen dioxide). While the FDA typically does not require including validation protocols or validation data in 510(k) submissions for medical devices sterilized by established methods, the FDA does request that sponsors submit validation protocols and validation data for medical devices sterilized by novel sterilization methods. As such, sponsors can expect to see additional scrutiny of 510(k) submissions for medical devices sterilized by novel sterilization methods.

With this 510(k) clearance, a pathway has been established for future 510(k) submissions for nitrogen dioxide sterilized medical devices.

Additional information can be found on the Noxilizer website here.

Among our product offerings, QTS helps many of our customers with sterilization validations and coordination of routine sterilization services. If you have questions about medical device outsourcing, please contact your QTS account manager, or email us at expert@qtspackage.com.

Filed Under: Blog

test

Stay informed on industry news.

Register here

Upcoming Events

  • MD&M West 2023
  • the[PACK]out 2023
  • OMTEC 2023
View Events »

Blog

  • Changing European Regulatory Requirements: Will your Medical Product be Affected?
  • What is Operational Excellence, and why is it Important to QTS?
  • QTS Collaborates with Other Industry Experts to Publish Best Practices Article on Tests of Sterility for EO Sterilization
View Blog »

Latest News

  • QTS Celebrates 20 Years in Business
  • QTS receives Global First in Sterile Device Packaging from MedAccred
  • QTS Presidential Transition
View News »

More Info

For more information on our services:

Contact us Download brochure

  • Terms of Use Policy
  • Website Privacy Policy
ISO 13485 Certified ISO 13485 Certified Med Accred Sterile Device Packaging

FDA Registered | J-PMDA Compliant


© 2023 Quality Tech Services, LLC